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Background: Ketosis is an important problem for dairy cows` production performance. However, it is still little
known about plasma metabolomics details of dairy ketosis.
Results: A gas chromatography/mass spectrometry (GC/MS) technique was used to investigate plasma metabolic
differences in cows that had clinical ketosis (CK, n=22), subclinical ketosis (SK, n=32), or were clinically normal
controls (NC, n=22). The endogenous plasma metabolome was measured by chemical derivatization followed by
GC/MS, which led to the detection of 267 variables. A two-sample t-test of 30, 32, and 13 metabolites showed
statistically significant differences between SK and NC, CK and NC, and CK and SK, respectively. Orthogonal signal
correction-partial least-square discriminant analysis (OPLS-DA) revealed that the metabolic patterns of both CK and
SK were mostly similar, with the exception of a few differences. The development of CK and SK involved
disturbances in many metabolic pathways, mainly including fatty acid metabolism, amino acid metabolism,
glycolysis, gluconeogenesis, and the pentose phosphate pathway. A diagnostic model arbitrary two groups was
constructed using OPLS-DA and receiver–operator characteristic curves (ROC). Multivariate statistical diagnostics
yielded the 19 potential biomarkers for SK and NC, 31 for CK and NC, and 8 for CK and SK with area under the
curve (AUC) values. Our results showed the potential biomarkers from CK, SK, and NC, including carbohydrates, fatty
acids, amino acids, even sitosterol and vitamin E isomers, etc. 2-piperidinecarboxylic acid and cis-9-hexadecenoic
acid were closely associated with metabolic perturbations in ketosis as Glc, BHBA and NEFA for dealing with
metabolic disturbances of ketosis in clinical practice. However, further research is needed to explain changes of
2,3,4-trihydroxybutyric acid, 3,4-dihydroxybutyric acid, α-aminobutyric acid, methylmalonic acid, sitosterol and
α-tocopherol in CK and SK, and to reveal differences between CK and SK.
Conclusion: Our study shows that some new biomarkers of ketosis from plasma may find new metabolic changes to
have clinically new utility and significance in diagnosis, prognosis, and prevention of ketosis in the future.
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Plasma metabolomeBackground
Ketosis is one of the most prevalent metabolic diseases
of dairy cows during transition period [1]. Considering
the serious consequences of ketosis such as fatty liver,
abomasum displacement, infectious diseases, and repro-
ductive diseases, this disease has become a health concern
during the past decades [2,3]. Therefore, elucidating the* Correspondence: xiacheng2011@gmail.com
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reproduction in any medium, provided the orpathogenesis of ketosis is of great importance to the
monitoring, prevention, and early treatment of ketosis.
To this end, there have been many reports about clinical
pathological changes in dairy ketosis. β-hydroxybutyrate
(BHBA) is widely considered the golden standard for
diagnosing ketosis in dairy cows. In addition, blood glu-
cose levels (Glc), total triglycerides (TG), nonesterified
fatty acids (NEFA), and aspartate aminotransferase (AST)
can also be analyzed to monitor ketosis-related complica-
tions [3-5]. However, to the best of our knowledge, theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Main characteristics and blood biochemical
parameters in normal control cows (NC), cows with
subclinical ketosis (SK), and cows with clinical ketosis (CK)
Parameters CK SK NC
Number 24 33 24
Days in milk 12±5 14±6 16±6
Age 3±1 3±1 4±2
Parity 2±1 2±1 2±1
MY (kg/d) 32.1±7.8Aa 35.2±7.2b 37.0±6.2Cc
BCS 3.05±0.31a 3.11±0.35 ab 3.16±0.37b
Glc (mmol/L) 1.90 ± 0.70A 2.70±0.63B 3.37±0.58C
BHBA (mmol/L) 2.49±0.60A 1.22±0.17B 0.82±0.12C
CHO (mmol/L) 2.36±0.70 2.45±0.68 1.98±0.80
AST (U/L) 113.13±23.74 113.29±27.46 102.58±28.58
TG (mmol/L) 0.13±0.40 0.16±0.50 0.13±0.57
Data are shown as mean ± SD, p < 0.05 or 0.01 among CK, SK, and NC groups
with different lowcase (a, b, c) or capital letters (A, B, C).
MY milk yield, BCS body condition score, DMI dry matter intake, Glc glucose,
BHBA β-hydroxyl acid, CHO cholerol, AST aspartate aminotransferase,
TG triglyceride.
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been clarified.
Metabolomics technology has proven to be a powerful
tool for biomarker screening, disease diagnosis, and char-
acterization of biological pathways in humans, rats, and
cattle [6-10]. In view of the high efficiency of chromato-
graphic separation and the sensitive detection of sepa-
rated components, gas chromatography/mass spectrometry
(GC/MS) is widely employed for the plasma metabolomic
profiling of diseases, in combination with multivariate
statistical analysis including principal component analysis
(PCA), partial least square-discriminant analysis (PLS-DA),
and orthogonal partial least square-discriminant analysis
(OPLS-DA), etc. [11,12].
Although milk and plasma metabolome of ketosis has
been reported using NMR technique [6,7], it is little known
about metabolome profiles of clinical and subclinical keto-
sis. In this study, a metabolomics approach by GC/MS in
conjunction with multivariate statistical analysis was devel-
oped to show alterations in plasma metabolite profiles of
cows associated with normal or enhanced ketone body
formation. Plasma samples from clinically normal cows
or those with subclinical or clinical ketosis were profiled
by GC/MS. Receiver operator characteristic curves (ROC)
and OPLS-DA, which finds new variables with optimal
discriminatory ability and small redundancy, were used to
explore perturbations in metabolic patterns and potential
biomarkers for clinical and subclinical ketosis.
Results and discussions
Comparison of demographics, clinical information and
blood chemical parameters
Clinical data from normal cows (NC) or those with sub-
clinical (SK) or clinical ketosis (CK) were collected to
uncover any biochemical differences among the three
groups shown in Table 1. Postpartum days, ages, parity,
daily milk yield (MY), and body condition score (BCS)
were comparable among the three groups of cows. There
were significant differences in MY and BCS plasma Glc
and BHBA concentrations among the three groups of
cows, but not in plasma AST, CHO, and TG. Our results
indicated that MY and BCS decreased significantly in
dairy cows with ketosis, which is consistent with some
reports that the affected cows often loss more milk yield
and body weight [13,14].
All affected cows mainly presented low MY, loss of
BCS, low blood Glc levels and high blood BHBA con-
centrations, which implies poor glucose regulation and
lipid profile disorders. Although the above mentioned
clinical biochemistry, such as Glc, BHBA, and AST levels,
may to some extent reflect the metabolic state of ketosis,
they only give limited information, as there are various
metabolic abnormalities that can exist during ketosis pro-
gression, as well as other underlying metabolic changesassociated with ketosis that can result in serious metabolic
outcomes such as fatty liver and infectious diseases [1-3].
Thus, metabolomics may provide a more global and
powerful approach for understanding the metabolic pat-
terns and potential biomarkers of ketosis, and addition-
ally, may shed light on the pathogenesis of ketosis in
dairy cows.
GC/MS metabolomic profiling
Figure 1 shows the three representative chromatograms
of derived plasma samples from the three groups of cows,
which had almost all same peaks among the three chro-
matograms, but there was also difference in peaks’ area
among them. After mean-centering, UV-scaling, and de-
convolution with AMDIS software, 40 of 267 variables
were only significantly different between groups by multi-
variate statistical analysis, and then were identified as
endogenous metabolites by NIST mass spectra library,
and were categorized as carbohydrates, amino acids, fatty
acids, sitosterol and vitamin E isomers, etc. (Table 2). Each
of these is involved in multiple biochemical processes,
especially those processes related to energy balance and
lipid metabolism.
Since the metabolic profiles of CK and SK were simi-
lar, multivariate statistical analyses were used to explore
biomarker candidates and disturbances in metabolic pat-
terns of ketosis. PCA was used to examine the clustering
of samples for differences in metabolic patterns among
the three groups. The PCA score plot could not differen-
tiate between CK, SK, and NC because the samples from
the three groups scattered into each other; however, they
could be successfully discriminated using the PLS-DA
Figure 1 The representative GC/MS chromatograms of plasma samples from No. 8 of normal control (NC, purple peaks) cows, No. 35 of
cows with subclinical ketosis (SK, brown peaks) and No. 68 of cows with clinical ketosis (CK, green peaks). X-axis is retention time (min);
Y-axis is intensity of MS (%).
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reduces dimensionality of the original data, was applied
to explore metabolic disturbances in, NC, SK, and CK.
The plot of PC1 (first principle component, t[1]P) versus
O (orthogonal component, t[2]O) is shown in Figure 2.
As illustrated in Figure 2, samples from the CK group
lay on the left side of t[1]P, while samples from SK and
NC lay in the middle and on the right side of t[1]P. In
addition, the parameters of OPLS-DA, R2Y and Q2, were
0.828 and 0.693, respectively. R2Y showed the explana-
tive ability of the model, and Q2 was the result of a
seven-fold cross-validation, and showed the predictive
ability of the model for metabolic profiling of the data
[15,16]. These results indicate that the proposed metabolic
process of ketosis was from NC to SK, and then to CK.
To further investigate the metabolic status and poten-
tial biomarkers of two groups, samples from two groups
were subjected to an OPLS-DA model. As can be seen
in Figures 3 (a, b, c), samples from the corresponding
two groups were distinctly separated on two sides of the
PC1 baseline. Furthermore, the OPLS-DA parameters,R2Y and Q2, were 0.819 and 0.74 for CK vs. NC, 0.856
and 0.595 for SK vs. NC, and 0.931 and 0.301 for CK vs.
SK, respectively. The results of the permutation test for
the R2 and Q2 intercepts were 0.645 and −0.279 for CK
vs. NC, 0.292 and −0.144 for SK vs. NC, and 0.323
and −0.105 for CK vs. SK, respectively. Thus, OPLS-DA
was suitable for exploring differences between two groups
in this study.
Metabolic disturbances of ketosis
Table 2 lists 21 decreased metabolites from the three
groups of cows, the majority of which were amino acids,
carbohydrates, and their metabolites; the minority of
which were carboxyl acids and hydroxyl acids from fatty
acids metabolism and the tricarboxylic acid (TCA) cycle.
Meanwhile it also shows the 19 increased metabolites,
the majority of which were non-esterified fatty acids (NEFA),
amino acids, and their metabolites; the minority of which
were carbohydrates, and even sitosterol and vitamin E
isomers, etc. These results suggest that metabolic dis-
turbances of ketosis involve in multi-biochemical pathways





CK vs. NC SK vs. NC CK vs. SK Biochemical pathwayg
VIPd Pe FCf VIPd Pe FCf VIPd Pe FCf
1 LA 5.68 147 1.88 2.62E-04 −0.79 2.13 4.90E-04 −0.73 Glycolysis;gluconeogenesis
2 GLCA 16.56 319 1.76 6.84E-04 −0.79 2.02 1.58E-03 −0.66 Pentose and glucuronate interconversions
3 L-ala 6.23 116 2.03 8.88E-05 −0.75 1.18 4.86E-02 −0.28 2.22 1.22E-03 −0.47 Alanine and aspartate metabolism
4 GA 5.87 147 1.89 1.53E-04 −0.56 2.12 5.94E-04 −0.48 Fatty acid metabolism
5 Ribitol 14.3 217 1.07 3.54E-02 −0.48 1.19 4.77E-02 −0.27 Glycolysis; Pentose phosphate Pathway
6 pGlu 11.83 156 1.54 2.83E-03 −0.43 1.34 1.77E-02 −0.29 Glutathione metabolism
7 Gal 16.03 73 1.83 9.86E-04 −0.38 1.85 3.02E-03 −0.61 Galactose metabolism
8 THBA 12.17 292 1.46 7.32E-04 −0.38 1.43 1.77E-02 −0.24 Fatty acid metabolism; Butanoate metabolism
9 Glc 16.21 319 1.66 2.98E-04 −0.31 1.77 2.78E-03 −0.22 2.26 2.15E-02 −0.14 Glycolysis/gluconeogenesis
10 Gly 9.05 174 1.45 1.62E-03 0.37 2.16 4.21E-05 0.45 Glycine, Serine and Threonine Metabolism
11 L-ile 8.87 158 1.67 1.72E-04 0.41 2.2 1.97E-05 0.44 Valine, leucine and isoleucine degradation
12 AABA 7.19 130 1.29 8.28E-03 0.53 1.94 1.89E-04 0.7 Fatty Acid Metabolism; Glycolysis; Glutamate metabolism;
13 AMA 11.19 218 1.35 2.58E-03 0.56 2.12 2.83E-05 0.67 dicarboxylic acid; malonate; biosynthetic formation
of glycine
14 αTP 26.16 502 1.79 6.08E-03 0.57 1.11 5.02E-02 0.41 Antioxidant
15 Sitosterol 28.57 357 2.25 7.58E-07 0.70 1.37 6.92E-03 0.41 1.69 1.71E-02 0.29 Steroid biosynthesis;immunity
16 HMA 13.68 129 1.79 2.42E-04 0.82 1.39 6.73E-03 0.47 cholesterol synthesis and fatty acid mobilization
17 3HV 8.05 147 1.86 9.89E-05 0.91 1.8 7.83E-03 0.59 2.59 1.57E-03 0.31 Valine, leucine and isoleucine biosynthesis
18 PA 17.26 117 2.04 4.68E-05 1.00 2.05 1.25E-04 0.77 Fatty acid metabolism
19 HA 18.17 327 2.08 1.18E-05 1.09 2.24 2.94E-05 0.75 2.08 3.68E-02 0.34 Fatty acid metabolism
20 SA 18.71 341 2.26 5.60E-07 1.14 2.22 4.30E-05 0.76 2.34 8.85E-03 0.37 Fatty acid metabolism
21 BHBA 7.02 147 2.58 2.83E-10 1.33 3.06 2.43E-10 0.81 3.32 4.49E-05 0.53 Synthesis and degradation of ketone bodies
22 T-9-OA 18.82 339 2.09 1.76E-06 1.39 2.45 3.75E-07 1.06 Fatty acid metabolism
23 MA 15.36 285 1.73 7.58E-05 1.58 2.22 4.87E-06 1.14 Fatty acid metabolism
24 C-9-HA 17.09 311 1.68 9.90E-05 1.66 2.15 6.81E-06 1.28 Fatty acid metabolism
25 2PC 10.23 156 2.19 4.12E-06 1.79 2.77 1.53E-09 1.78 Lysine metabolism
26 L-ser 9.77 204 1.34 1.43E-02 −0.49 2.37 3.36E-04 −0.43 Glycine, serine, and threonine metabolism
27 GABA 11.91 84 1.73 2.91E-04 −0.71 2.27 8.44E-04 −0.48 Fatty acid metabolism; Glycolysis; Glutamate metabolism;
Pyruvate metabolism
28 Melibiose 24.37 204 1.05 2.19E-02 −0.66 Arginine and proline metabolism
29 Erythritol 11.72 147 1.1 1.75E-02 −0.43 Galactose metabolism


















Table 2 Marker metabolites found in the GC/MS chromatograms of any two groups of CK, SK, and NC (Continued)
31 2Me3HB 7.53 117 1.34 5.91E-03 0.36 Valine, leucine and isoleucine biosynthesis
32 Xylitol 14.11 307 1.2 5.67E-03 0.42 Fatty acid metabolism; ketogenesis
33 4HYP 11.88 230 1.61 5.97E-03 0.47 1.3 2.90E-02 −0.24 Glycolysis; Pentose phosphate Pathway
34 L-orn 15.17 142 1.16 6.00E-02 −0.68 Urea Cycle; D-arginine and D-ornithine metabolism
35 MMA 8.53 319 1.33 1.83E-02 −0.39 dicarboxylic acid;malonate
36 2-KG 12.47 73 1.17 4.48E-02 −0.26 TCA Cycle; Glycolysis
37 L-leu 8.57 158 1.28 1.84E-02 0.19 Valine, leucine, and isoleucine metabolism
38 Citrate 15.24 73 1.72 7.87E-03 −0.59 TCA Cycle
39 DHBA 10.7 73 2.28 1.75E-02 −0.29 Fatty acid metabolism; Butanoate metabolism
40 L-pro 8.91 142 1.53 1.43E-02 −0.22 Arginine and proline metabolism
aSignificant changes in the levels of corresponding metabolites between arbitrary two groups by the ANOVA and t-test (P < 0.05).
2PC 2-piperidinecarboxylic acid, C-9-HA cis-9-hexadecenoic acid, MA myristic acid, T-9-OA Trans-9-octadecenoic acid, BHBA 3-hydroxybutyric acid, SA stearic acid, HA heptadecanoic acid, PA palmitic acid,
3HV 3-hydroxyvaleric acid, HMA 3-hydroxy-3-methylglutaric acid, αTP α-tocopherol, AMA aminomalonic acid, AABA α-aminobutyric acid, L-ile l-isoleucine, Gly glycine, Glc Glucose, THBA 2,3,4-trihydroxybutyric acid,
Gal galactose, pGlu pyroglutamic acid, GA glycolic acid, L-ala l-alanine, GLCA glucuronic acid, LA lactic acid, GABA 4-aminobutyric acid, L-ser l-serine, 4HYP 4-hydroxyproline, 3-HIV 3-hydroxyisovaleric acid,
2Me3HB 2-methyl-3-hydroxybutyric acid, L-orn l-ornithine, MMA methylmalonic acid, 2-KG 2-ketoglutaric acid, L-leu l-leucine, Cit citrate, DHB 3,4-dihydroxybutyric acid, L-pro, l-proline.
bRetention time.
cPeaks in total ion chromatograms (TICs) are numbered according to their retention time. The identification of a metabolite is based on National Institute of Standards and Technology (NIST08) mass spectra database
according to the match of masses (m/z) between the interested peak’s fragmentation pattern and that from the standard database.
dVariable importance in the projection (VIP) was obtained from OPLS-DA model with value higher than 1.0.
eThe p-value calculated from two-tailed student's t test.
fFold change (FC) was calculated as binary logarithm of average mass response ratio between two groups, where the positive value means that the average mass response of the metabolite in the former is larger
than that in the latter and vice versa.


















Figure 2 Score plot of OPLS-DA among three groups after excluding three outlier samples from Group CK, SK and NC respectively.
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ism, fatty acids metabolism, pentose phosphate pathway.
In the current study, potential metabolites from arbi-
trary two groups were found to be significantly changed
based on the largest VIP and a students t-test (P < 0.05).
Table 2 summarizes 40 potential biomarkers that were
differentially found in the CK, SK, and NC groups, which
25 metabolites were the same in both CK and SK, includ-
ing 7 metabolites in CK vs. SK, indicating that CK and SK
have rather similar pathogenesis.
Figure 4a shows that nine of the 25 metabolites; namely,
lactic acid (LA), glucuronic acid (GLCA), l-alanine (L-ala),
glycolic acid (GA), ribitol, pyroglutamic acid (pGlu), gal-
actose (Gal), 2,3,4-trihydroxybutyric acid (THBA), and
glucose (Glc), decreased from low to high in both CK
and SK compared to NC. With the exception of L-ala in
CK vs. SK and Gal in SK vs. NC, fold changes of other
decreased metabolites are in turn low from CK vs. NC
to SK vs. NC, and CK vs. SK. LA, L-ala, and pGlu from
glucogenic amino acids and THBA from glucogenic
and ketogenic threonine, which may be converted into
glucose in liver by gluconeogenesis [17-20]. Low pGlu
values may indicate glutathione deficiency due to oxi-
dative stress [17]. Thus, gluconeogenesis decreased in
both CK and SK because of a decrease in these glucogenic
amino acids. In addition, GLCA, ribitol, Gal, and Glc can
play a role in energy metabolism by entering glycolysis
via the pentose phosphate pathway [21-24]. Decreased
ribitol levels may be related to riboflavin deficiency [22].
Vitamin C may also be involved in energy metabolism
due to GLCA, which is derived from vitamin C [21].Therefore, a low level of plasma carbohydrates may play
an important role in the development of ketosis, and
low vitamin C and B2 levels, as well as oxidative stress,
may also be contributing factors. It is also worth noting
that a decrease in GA may reduce milk components in
both CK and SK, since GA is used to synthesize milk
fat or lactose [25]. GLCA and LA may play important
roles in maintaining energy balance because they were
maximally down-regulated in both CK and SK. In brief,
our study suggests that ketosis is closely associated with
disturbances in carbohydrate metabolism due to hypo-
glycemia and a lack of glucogenic precursors such as LA
and L-ala. Vitamin C and B2 deficiencies, oxidative stress,
and low GLCA and LA, may also contribute to the devel-
opment of this disease.
Figure 4a also shows that 16 of 25 metabolites in-
creased in both CK and SK compared to NC. With the
exception of aminomalonic acid (AMA), α-aminobutyric
acid (AABA), l-isoleucine (L-ile), and glycine (Gly), fold
changes of other metabolites increased in turn from CK
vs. NC to SK vs. NC, and CK vs. SK. These metabolites
were mainly increased 3-hydroxybutyric acid (BHBA) and
nonesterified fatty acids (NEFAs), including palmitic acid
(PA), heptadecanoic acid (HA), stearic acid (SA), trans-9-
octadecenoic acid (T-9-OA), myristic acid (MA), cis-9-
hexadecenoic acid (C-9-HA), which belong to the families
of ketone bodies, long chain unsaturated fatty acids,
and saturated acids [1,26], confirming that a great amount
of fat mobilization resulting from hypoglycemia may cause
ketosis. In addition, some up-regulated amino acids
and their catabolic products, such as L-ile, a glucogenic
Figure 3 The OPLS-DA scores plot and ROC plot of plasma obtained from arbitrary two groups. (a, b, c) Score plot of OPLS-DA of using
Principal Component 1 (PC1) in Group CK vs. NC, Group SK vs. NC, and Group CK vs. SK respectively; (d, e, f) ROC plot of cis-9-hexadecenoic acid,
2-piperidinecarboxylic acid, and 3-hydroxybutyric acid in the diagnosis in Group CK vs. NC, Group SK vs. NC, and Group CK vs. SK respectively.































































































Figure 4 Intensity of metabolites from CK compared to NC (blue column), SK compared to NC (red column), and CK compared to SK
(yellow column). (a) Expression intensity of 25 identical metabolites from CK vs. NC and SK vs. NC, including 7 metabolites from CK vs. SK. 2PC,
2-piperidinecarboxylic acid; C-9-HA, cis-9-hexadecenoic acid; MA, myristic acid; T-9-OA, Trans-9-octadecenoic acid; BHBA, 3-hydroxybutyric acid; SA,
stearic acid; HA, heptadecanoic acid; PA, palmitic acid; 3HV, 3-hydroxyvaleric acid; HMA, 3-hydroxy-3-methylglutaric acid; VE, vitamin E (α-tocopherol);
AMA, aminomalonic acid; AABA, α-aminobutyric acid; L-ile, l-isoleucine; Gly, glycine; Glc, Glucose; THBA, 2,3,4-trihydroxybutyric acid; Gal, galactose;
pGlu, pyroglutamic acid; GA, glycolic acid; L-ala, l-alanine; GLCA, glucuronic acid; LA, lactic acid. (b) Expression intensity of 15 different metabolites from
three groups. GABA, 4-aminobutyric acid; L-ser, l-serine; 4HYP, 4-hydroxyproline; 3-HIV, 3-hydroxyisovaleric acid; 2Me3HB, 2-methyl-3-hydroxybutyric
acid; L-orn, l-ornithine; MMA, methylmalonic acid; 2-KG, 2-ketoglutaric acid; L-leu, l-leucine; Cit, citrate; DHB, 3,4-dihydroxybutyric acid; L-pro, l-proline.
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serine [27]; AMA, a constituent of proteins before hy-
drolysis [28]; and 2-piperidinecarboxylic acid (2PC), a
metabolite of the lysine metabolism [29]; suggest that
proteolysis increases to meet body energy demand in
both CK and SK. Since 2PC up-regulation was highest
in both CK and SK, it may play an important role in
ketone body synthesis as a catabolic product of keto-
genic lysine [29]. In addition, the up-regulation of other
metabolites, such as 3-hydroxyvaleric acid (3HV), 3-hydroxy-
3-methylglutaric acid (HMG), and AABA, implicated ab-
normal metabolic changes or functional abnormalities
in both CK and SK, since high 3HV concentrations can
be found in methylmalonic acidemia [30], increased HMG
values may be caused by decreased coenzyme Q10 syn-
thesis [31], and elevated AABA levels can be indicative
of liver disease [32]. However, it still remains unknown
whether they play roles in the development of ketosis.
Interestingly, we observed high sitosterol and vitamin Eisomers in sick cows. In view of the anti-inflammatory
property of sitosterol and the anti-oxidative role of
α-tocopherol [33,34], those cows can not effectively
utilize them, rendering them susceptible to infectious
diseases and oxidative stress. However, it might be that the
host responds to sickness by increasing those metabolites.
It might be also both ways. Therefore, Need more
search to see why they are high.
Although CK and SK had many of the same metabo-
lites in both CK and SK, some different metabolites
were also found between the two groups, as is shown in
Figure 4b. Specifically, seven different metabolites in-
creased in CK vs. NC, including 2-methyl-3-hydroxybutyric
acid (2Me3HB) is a metabolite from isoleucine catabolism,
β-oxidation of fatty acids and ketogenesis [25], and xylitol,
is a precursor of xylulose 5-phosphate, and an intermediate
of the pentose phosphate and glycolytic pathways [35].
The decreased metabolites included 3-hydroxyisovaleric
acid (3HIV) from catabolism of the ketogenic amino
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glutamic acid catabolism [37], melibiose from galactose
metabolism [25], erythritol, a precursor of fructose 6-
phosphate [38], and l-serine (L-ser), a glucogenic and
ketogenic amino acid [39]. The results suggest that these
carbohydrates and amino acids may be important factors
in the development of CK. In addition, five different
metabolites were up-regulated in SK compared to NC,
and included 4-hydroxyproline (4-HYP) from proline
hydroxylation [40], and l-leucine (L-leu), which is a ke-
togenic amino acid [19]. Down-regulated metabolites
between the two groups included 2-ketoglutaric acid
(2-KG), which is involved in the TCA cycle [41], l-ornithine
(L-ori), which participates in the urea cycle [42], and
methylmalonic acid (MMA), which is from a C-methylated
derivative of malonate [43]. These results indicate that SK
may disturb the TCA cycle, urea cycle, and odd-numbered
fatty acid metabolism. Therefore, a few different metabo-
lites had been found in CK or SK in this study, suggesting
that they may play certain roles in identifying develop-
ment process or types of ketosis.
Finally, Figure 4b shows the six metabolites that de-
creased in CK compared to SK; namely, GABA; L-ser;
4HYP; citrate; 3,4-dihydroxybutyric acid (DHB); l-proline
(L-pro). Citrate is an intermediate in the TCA cycle [44].
DHB may be a product of amino acid catabolism [45].
L-pro is an important component of collagen and is de-
rived from the amino acid l-glutamate [46]. Therefore, a
decrease of the above mentioned metabolites, especially
citrate, can further aggravate ketosis due to interruption
of TCA cycle and lack of amino acids. Our research may
shed light on the clinical potential of some potential
metabolites in the development of ketosis.
In Table 2, long or medium-chain fatty acids and hy-
droxyl acids such as C-9-HA, MA, BHBA, and 2PC, etc.
increased significantly in SK and CK compared with NC
while metabolites such as 3-HV and 3-HIV changed dif-
ferently in SK and CK group. The decreased metabolites
were mainly some compounds such as LA, L-ala, GLCA,
GA, Gal, Glc, etc., which are relative to glycolysis and
TCA cycle. Thus, those metabolites may become poten-
tial biomarkers for diagnosing ketosis including SK and
CK in dairy cows.
However, there were less differential metabolites in
CK vs SK groups. Long or medium-chain fatty acids and
hydroxyl acids such as HA, SA, BHBA, 3-HV ect. in-
creased significantly in CK compared with SK, but amino
acids like L-ala, L-ser, L-pro, 4-HYP, and GABA & citrate
and DHBA decreased significantly. Therefore, those me-
tabolites may be potential biomarkers for distinguishing
the serious degree of ketosis in dairy cows.
In general, many metabolic pathways are disturbed in
the development of ketosis. The supply of amino acids
for gluconeogenesis decreases because there is a negativeenergy balance (NEB) in both CK and SK. In the mean-
time, the huge energy requirement for cow milk produc-
tion after calving causes increased availability of fatty
acids for oxidation, which displaces glucose as the oxida-
tive fuel. In NEB situations, hypoglycemia activates fat
mobilization, leading to NEFAs accumulation in liver,
production of advanced glycolic end products, and in-
creased oxidative stress, which result in many metabolic
dysfunctions. The role of certain intermediates like THBA,
DHBA, AABA, and MMA in the development of ketosis
is worthy of further exploration in order to understand
metabolic disturbances in ketosis.
Diagnostic test and receiver–operator characteristic
curves (ROC)
PCA, PLS-DA, and OPLS-DA, the most commonly used
algorithms in metabolomics [33,46], were employed to
process the GC/MS data. The OPLS-DA score plot showed
that the two groups were scattered into two different re-
gions using PC1 (Figures 3a, 3b, 3c). ROC analysis using
the cross-validated predicted Y (predicted class) values
was performed to validate the robustness of the OPLS-DA
model. Sensitivity and specificity tradeoffs were summa-
rized for each variable in Table 3, such as C-9-HA for
CK vs. NC, 2PC for SK vs. NC, and BHBA for CK vs.
SK, using the area under the curve (AUC), and were
calculated using the trapezoidal rule (Figure 3d, AUC
0.907 in CK vs. NC; Figure 3e, AUC 0.923 in SK vs. NC;
Figure 3f, AUC 0.953 in CK vs. SK). It has been reported
that ROC analysis is able to determine easily ability for
identifying disease at any cutoff. AUC value from ROC
is usually between 1.0 and 0.5. AUC is more close to 1,
the higher the accuracy test is, and the bigger the diag-
nostic value is , then the less false positive or negative
ratio is [47,48]. In addition, the bigger positive likeli-
hood ratio (+LR) is, the higher the true positive prob-
ability is [48,49]. According to AUC values and +LR of
any two groups in Table 3, 31 metabolites for CK vs NC,
19 for SK vs NC, and 8 for CK vs SK may be potential
biomarkers for identifying ketosis. Of course, those
metabolites with high AUC values and high fold changes
will be better potential diagnostic biomarkers for detec-
tion and classification of ketosis in the future.
In this study, the detected metabolites that were differ-
entially found between CK and SK were closely related
to alterations in carbohydrates, fatty acids, amino acids,
even sitosterol and vitamin E isomers, etc. Our study con-
firmed that BHBA is an excellent biomarker for ketosis
including CK and SK, which has long been considered a
gold indicator for diagnosing ketosis [2,3]. Hypoglycemia
was the main biochemical characteristics in CK and SK
(Table 1), which is in accordance with the metabolomics
results in Table 2. Furthermore, C-9-HA, which belongs
to the NEFA family, was significantly increased in CK
Table 3 The potential diagnostic biomarkers of any two
groups of CK, SK, and NC
No Compoundsa CK vs NC SK vs NC CK vs SK
LR+b AUCc LR+b AUCc LR+b AUCc
1 GA 0.25 0.122 0.38 0.176
2 L-ala 0.06 0.149 0.30 0.216
3 L-ser 0.36 0.240
4 GLCA 0.19 0.153 0.05 0.19
5 Erythritol 0.28 0.161
6 Ribitol 0.26 0.171
7 Glc 0.24 0.176 1.07 0.259
8 LA 0.07 0.178 0.18 0.199
9 Gal 0.34 0.184 0.42 0.22
10 GABA 0.15 0.221 0.26 0.261
11 DHB 0.36 0.257
12 THB 0.38 0.231
13 pGlu 0.47 0.269
14 MMA 1.01 0.283
15 Melibiose 1.05 0.277
16 Citrate 0.42 0.281
17 3HV 2.32 0.79
18 AABA 11.80 0.79
19 L-leu 1.89 0.638
20 Xylitol 3.16 0.752
21 Gly 2.33 0.76 7.90 0.837
22 2Me3HB 3.60 0.764
23 AMA 2.57 0.773 3.09 0.822
24 AABA 1.05 0.773
25 αTP 2.37 0.783
26 L-ile 3.16 0.814 3.32 0.827
27 HMG 4.07 0.848
28 Sitosterol 3.00 0.88 1.91 0.741
29 PA 6.35 0.897 5.29 0.838
30 C-9-HA 3.81 0.909 2.75 0.842
31 Hep 7.02 0.911 5.15 0.866
32 MA 6.01 0.913 3.21 0.845
33 SA 6.35 0.913 3.44 0.842
34 2PC 4.97 0.918 7.78 0.923
35 T-9-OA 4.21 0.924 3.58 0.868
36 3HV 9.09 0.95 2.38 0.764
37 BHBA 10.22 0.977 8.13 0.965 5.11 0.953
aAbbreviations of compounds’ name are same as Table 2.
b+LR, positive likelihood ratio.
cAUC, area under the curve. If AUC value is more than 7.00 or less than 0.30,
compound is considered to be a potential diagnostic biomarker of disease.
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fat mobilization. However, Glc and the NEFA family could
not become potential biomarkers for distingushing CK
and SK. In addition, the increased 2PC in SK compared to
NC, which has not been previously reported as a potential
biomarker, suggested that some new biomarkers may play
important roles in the pathogenesis and development
of ketosis in dairy cows.
Conclusion
The present study is an integrated analysis in dairy cattle
ketosis based on plasma metabolomic profiling by GC/
MS. We first discovered that 40 metabolites (i.e. fatty
acids, amino acids, carbohydrates, and others) were dif-
ferentially found among CK, SK and NC. This proved
that metabolic patterns of ketosis could be reflected by
metabolomics technology, which could, to some extent,
reveal the development and progression of ketosis. To
research ketosis, potential biomarkers of CK and SK
could uncover the same or different modes of metabo-
lites and metabolic pathways in the development and
progression of ketosis. Furthermore, new potential me-
tabolites could shed light on new strategies for the diag-
nosis, prognosis, and prevention of ketosis in the future.
Methods
Animals and sample collection
All experimental animals were treated according to the
International Guiding Principles for Biomedical Research
Involving Animals. Twenty-two cows with clinical ketosis
(CK), 32 cows with subclinical ketosis (SK), and 22 normal
control cows (NC) from an intensive 1000 dairy cattle
farm in Mishan, Heilongjiang, China were used in this
exploratory study. All cows were fed a total mixed ra-
tion (TMR) during the transition period. TMR consisted of
8.5 kg of concentrated feed, 18.5 kg of silage maize, 4 kg
of alfalfa, and 0.35 kg of fat. TMR consisted of 55.60%
dry matter (DM), 16% crude protein, 1.75 mcal/DM net
energy for lactation (NEL), 5.60% fat, 39.10% neutral
detergent fiber (NDF), 20.30% acid detergent fiber (ADF),
180 g Ca, and 116 g P. The cows were considered to
have CK if they showed typical clinical symptoms in-
cluding lack of appetite, apparent wasting, low milk yield,
even nervous signs etc., and had high plasma BHBA con-
centrations ( > 1.60 mmol/L). If the cows had little clin-
ical symptoms and high plasma BHBA concentrations
(> 1.20 mmol/L), they were considered to have SK. If
the cows had no clinical signs and normal plasma BHBA
concentrations (< 1.00 mmol/L), they were considered
normal controls (NC) [3,4]. Within 12 h of calving, whole
first-morning blood samples were collected and immediately
centrifuged at 1400 × g for 10 min at room temperature.
The supernatants were aliquoted into Eppendorf tubes
(1 mL plasma/tube) and stored at −80°C until analysis.
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measured for all experimental animals. Main character-
istics and blood biochemical parameters, which in-
cluded age, parity, milk yield (MY, kg/d), body condition
score (BCS), blood glucose (Glc), β-hydroxaybutyric acid
(BHBA), triglycerides (TG), aspartate aminotransferase
(AST), and cholesterol (CHO), are shown in Table 1.
Sample preparation
The sample preparation was modified according to litera-
ture [48,49] and described as follows. To an Eppendorf
tube were added 50 μL of thawed plasma at room
temperature, 10 μL 13C6-Leucine (0.5 mg/mL in water,
as internal standard), and 180 μL cold methanol. The
mixture was vigorously vortexed for 30 s and centrifuged
at 16 000×g for 15 min at 4°C, and then 192 μL of the
supernatant was transferred to a glass vial for drying
under gentle nitrogen stream. A volume of 80 μL of
methoxylamine hydrochloride in pyridine (20 mg/mL)
was added to the residue, and the solution was strongly
vortexed for 30 s and incubated at 37°C for 90 min. The
sample was derivatized using 80 μL N,O-bis (trimethylsilyl)-
trifluoroacetamide (BSTFA) with 1% trimethylsilyl chloride
(TMCS) at 70°C for 60 min. To avoid decomposition,
all derivatized samples were analyzed within 48 h by
GC/MS (Agilent 7890A GC /5975C MS).
Data preprocessing and multivariate statistical analysis
The extraction, alignment, deconvolution, and further
processing of raw GC/MS data were referred to the pro-
tocols of literature [47-49], except the mass window was
set to 70–600 m/z. The preprocessed data table, includ-
ing observations (sample name), variables (rt_mz), and
summarized peak area, was imported into Simca-P 11.0
software (Umetrics AB, Umea, Sweden) for multivariate
statistical analysis, where mean-centering and UV-scaling
were employed prior to PCA, PLS-DA, and OPLS-DA.
Principal component analysis (PCA) was initially performed
for visualizing the trends of samples in this study. To
remove the noise, partial least square-discriminant ana-
lysis (PLS-DA) and orthogonal partial least square-
discriminant analysis (OPLS-DA) were utilized to explore
differences among groups. PLS-DA was used to model
the metabolic profiling data among CK, SK, and NC.
OPLS-DA filtered unrelated factors to CK, SK, and NC
in the metabolic profiling. Model parameters, R2Y and
Q2, were applied to evaluate model stability and the
ability to explain and predict the raw data. In addition,
the possibility of over-fitting was tested using the per-
mutation test [11,12,15].
Identification and qualification of differential metabolites
Differential metabolites (i.e., potential biomarkers) between
arbitrary two groups were found by combining VariableImportance in Projection (VIP >1) values of the OPLS-
DA model and students t-test (P <0.05). The structural
qualification of potential biomarkers was performed ac-
cording to the method of literature [5-7]. The automated
mass spectral deconvolution and identification system
(AMDIS, National Institute of Standards and Technology,
Gaithersburg, MD) was first utilized to deconvolute mass
peaks and search the self-constructed standard library by
matching retention time and mass spectra pattern. The
peaks which were not matched from standard library
were introduced to the NIST MS 2.0 software for auto-
matically searching from the NIST 08 library. The peaks
with matching similarity larger than 80% were assigned
as candidate compounds.
Statistical analysis
Variance was used to analyze the some information based
on the diagnoses of CK, SK, and NC. All data processed
by ANOVA (SPSS for Windows version 11.0) were pres-
ented as mean ± standard deviation (SD). P values of
less than were considered to indicate a significant differ-
ence. In addition, the receiver operating characteristic
(ROC) analysis was carried out using SPSS, and the AUC
value, specificity, sensitivity were calculated to evaluate
the diagnostic value of the potential biomarkers from
the differential metabolites of the disease. P values of
less than 0.05 were considered to indicate a significant
difference [47-49].
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